| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
INSERM U 349 (M.E.C-S., M.A.D., M.C.deV.), Centre Viggo Petersen, Laboratoire de Biologie Endocrinienne (O.B-P., A.M.G.), Hopital Lariboisière, 75010 Paris; and Department of Hormonology (F.B., M.B.), Hopital Sud, Amiens, France
Address all correspondence and requests for reprints to: Dr. M. Cohen-Solal, INSERM U349, Centre Viggo Petersen, Hopital Lariboisière, 6 Rue Guy Patin, 75010 Paris, France.
Accelerated bone loss occurs in the years after menopause, and is an
ongoing phenomenon in elderly women. The role of cytokines in bone loss
after estrogen deficiency has been shown in ovariectomized rat and mice
models. In humans, the involvement of bone resorbing cytokines is now
well established. In the early years after menopause, monocyte
activation leads to increased cytokine production. We have previously
shown that the bone resorbing activity (BRA) of peripheral blood
monocyte culture supernatants from postmenopausal women is higher than
in premenopausal (Pre-M) women. This increased activity was related to
interleukin (IL)-1, IL-6, and tumor necrosis factor-
levels. We here
investigate whether monocyte activation still occurs in older women and
whether this relates to bone resorption. We studied 19 healthy Pre-M,
and 24 early (E-Post-M, menopause <10 yr) and 24 late (L-Post-M,
menopause >10 yr) postmenopausal women. Peripheral blood monocytes
were cultured for 48 h with 20% autologous plasma. BRA of
monocyte supernatants (expressed as the ratio of monocyte supernatant
over control bones supernatant) was assessed using fetal long-bone
resorbing assays. Bone resorption was determined by urinary total
pyridinoline excretion. BRA was significantly increased in E-Post-M and
L-Post-M, compared with Pre-M subjects (1.20 ± 0.10 and 1.15
± 0.20 vs. 0.73 ± 0.10, respectively, both
P < 0.05). Moreover, BRA of bones cultured with
the supernatant of Pre-M was lower than BRA of control bones. BRA was
significantly correlated with levels of IL-1, IL-6, and tumor necrosis
factor-
in supernatant. Supernatant IL-1 levels were increased in
E-Post-M, compared with Pre-M women (506 ± 180 vs.
122 ± 30, P < 0.05). Similarly, pyridinoline
levels were increased in E-Post-M and L-Post-M, compared with Pre-M
subjects (8.8 ± 1 and 10.5 ± 0.9 vs.
5.8 ± 0.5, respectively, both P < 0.05). BRA
was significantly correlated to pyridinoline levels. These data
indicate the presence of monocyte activation in L-Post-M, which may be
responsible for the increased bone resorption and bone loss observed in
this elderly population.
This article has been cited by other articles:
![]() |
Y.-Z. Liu, V. Dvornyk, Y. Lu, H. Shen, J. M. Lappe, R. R. Recker, and H.-W. Deng A Novel Pathophysiological Mechanism for Osteoporosis Suggested by an in Vivo Gene Expression Study of Circulating Monocytes J. Biol. Chem., August 12, 2005; 280(32): 29011 - 29016. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. ARIS, A. R. STEPHENS, D. A. ONTJES, A. DENENE BLACKWOOD, R. K. LARK, M. B. HENSLER, I. P. NEURINGER, and G. E. LESTER Adverse Alterations in Bone Metabolism Are Associated with Lung Infection in Adults with Cystic Fibrosis Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1674 - 1678. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |